US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ProShares UltraShort Lehman 7-10 Year Treasury

22.60

-0.1650-0.72%

Volume:1.94K

Turnover:43.93K

Market Cap:14.69M

PE:- -

High:22.71

Open:22.71

Low:22.60

Close:22.76

Loading ...

Overview Company News Filings

New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI)

ACCESS Newswire

New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

ACCESS Newswire

Press Release: Advisory for Thursday, Feb. 27: Edison International to Hold Conference Call on Fourth Quarter and Full-Year 2024 Financial Results

Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma

Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

Press Release: Logitech Announces Date for Release of Third Quarter Results for Fiscal Year 2025

Faraday Future to Host Exclusive Private Showcase and Experience of FX Prototype Mules in Las Vegas, NV

Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

New to the Street Show #617 Airs Tonight on Fox Business at 10:30 PM PST as Sponsored Programming

L.B. Foster Company to Present at Singular Research’s Best of the Uncovereds Conference on December 12, 2024

Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting

Daiichi Sankyo Highlights Progress Across Oncology Portfolio in Multiple Solid and Blood Cancers at ESMO Asia, SABCS and ASH

New to the Street to Showcase Innovators in Electric Vehicles, Water Solutions, Environmental Conservation, and Cybersecurity on Fox Business: Episode 612 Airs Monday, November 18 at 10:30 PM PST

Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS

AstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024

Aemetis to Review Third Quarter 2024 Financial Results on November 12, 2024

Elevance Health Announces Appearance at UBS Global Healthcare Conference

LogicMark, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PST/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PST\",,,,,undefined,":{"symbol":"PST","market":"US","secType":"STK","nameCN":"ProShares UltraShort Lehman 7-10 Year Treasury","latestPrice":22.595,"timestamp":1745956800000,"preClose":22.76,"halted":0,"volume":1941,"delay":0,"floatShares":650000,"shares":650000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.165,"latestTime":"04-30 08:01:24 EDT","open":22.71,"high":22.71,"low":22.595,"amount":43926.811,"amplitude":0.005053,"askPrice":25.04,"askSize":100,"bidPrice":20.33,"bidSize":100,"shortable":3,"etf":-2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746019800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":22.595,"sharesOutstanding":650000,"nav":22.7608,"aum":14794520,"bidAskSpread":0.004885,"postHourTrading":{"tag":"盘后","latestPrice":22.595,"preClose":22.595,"latestTime":"16:05 EDT","volume":2,"amount":45.19,"timestamp":1745957109926},"volumeRatio":0.19432931033515927,"impliedVol":0.1885,"impliedVolPercentile":0.8353},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PST\",,,,,undefined,":{"symbol":"PST","floatShares":650000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.19432931033515927,"shares":650000,"dividePrice":0.86678,"high":22.71,"amplitude":0.005053,"preClose":22.76,"low":22.595,"week52Low":18.8,"pbRate":"--","week52High":25.035,"institutionHeld":0,"latestPrice":22.595,"eps":0,"divideRate":0.038362,"volume":1941,"delay":0,"ttmEps":0,"open":22.71,"prevYearClose":23.9678,"prevWeekClose":22.92,"prevMonthClose":22.92,"prevQuarterClose":22.92,"fiveDayClose":23.35,"twentyDayClose":22.92,"sixtyDayClose":24.125},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PST\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518276435","title":"New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276435","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518276435?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:35","pubTimestamp":1741617300,"startTime":"0","endTime":"0","summary":"The Sustainable Green Team , with Kevin Harrington, \"Original Shark Tank\" Investor, and CEO Tony Raynor, Features Sponsor with Full Interview Link. Plus, the Debut of the New Roadzen $RDZN TV Commercial. NEW YORK CITY, NY / ACCESS Newswire / March 10, 2025 / New to The Street, one of the longest-running national business TV shows, announces tonight's airing of Show 633 on the Fox Business Network at 10:30 PM PST as sponsored programming.Since its launch in 2009, New to The Street has produced 635 episodes, making it one of the most consistent and impactful business TV platforms in the industry.The episode features exclusive interviews with top executives from Zapp Electric Vehicles , BioVie , PetVivo , and Banzai , providing viewers with insights into their latest business developments and industry innovations.Zapp offers a high-quality direct-to-customer experience known as DSDTC . Custome","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/street-show-633-broadcast-fox-143500345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BIVI","ZAPPW","PST","BK4120","PETV","BK4139","BNZIW","ZAPP","BK4091","SGTM","BK4023","BNZI"],"gpt_icon":0},{"id":"2516694249","title":"New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce","url":"https://stock-news.laohu8.com/highlight/detail?id=2516694249","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516694249?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:40","pubTimestamp":1741052400,"startTime":"0","endTime":"0","summary":"Also Featuring The Sustainable Green Team  with Shark Tank’s Kevin Harrington Showcasing Their WaterLess Garden Product. Additionally, the episode will spotlight The Sustainable Green Team  with Shark Tank's Kevin Harrington, discussing the company's groundbreaking WaterLess Garden product-an eco-friendly solution tackling water conservation challenges in agriculture and landscaping.\"We are excited to be going on our 17th year and will hit our 700th show this year,\" said Vince Caruso, Co-Founder and CEO of New to The Street. \"Additionally, we are adding T.V. commercial support across the board for our brand and clients to educate the public weekly.\". With a multi-platform strategy that combines broadcast television, earned media, social engagement, and strategic outdoor placements, New to The Street continues to expand its reach, providing companies with unparalleled exposure across major media channels.Never miss an interview-an \"Opportunity To Consider\" again!A clinical-stage biophar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/street-airs-show-630-fox-014000774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","BK4127","QID","PSQ","NVIW.SI","PST","EXOZ","QLD","ATCH","NQmain","BK4023","RDZN",".IXIC","TSYW.SI","MNQmain","TQQQ","USAW.SI","BK4139","RDZNW","BIVI","SQQQ"],"gpt_icon":1},{"id":"2507526569","title":"Press Release: Advisory for Thursday, Feb. 27: Edison International to Hold Conference Call on Fourth Quarter and Full-Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2507526569","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507526569?lang=en_us&edition=fundamental","pubTime":"2025-01-29 05:06","pubTimestamp":1738098360,"startTime":"0","endTime":"0","summary":"Advisory for Thursday, Feb. 27: Edison International to Hold Conference Call on Fourth Quarter and Full-Year 2024 Financial Results. WHAT:        Fourth Quarter and Full-Year 2024 Financial Results. NUMBERS:     1-888-673-9780 -- for callers in the U.S.replay will be available through March 12 at 6 p.m.  at the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMG7P587.USD","EIX","LU2362540622.SGD","IE00BMG7P694.USD","LU2362541513.USD","BK4588","IE00BMG7P819.SGD","LU2449327464.USD","BK4081","PST","LU2362541273.HKD","BK4585","IE00BMG7P926.USD"],"gpt_icon":0},{"id":"2505090054","title":"Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2505090054","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505090054?lang=en_us&edition=fundamental","pubTime":"2025-01-23 21:00","pubTimestamp":1737637200,"startTime":"0","endTime":"0","summary":"Data corroborate previously reported preclinical data demonstrating certepetide’s ability to enhance the effectiveness of immunotherapy Preliminary results to be presented at the 2025 ASCO Gastrointes","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/23/3014226/18623/en/Lisata-Therapeutics-and-WARPNINE-Announce-Encouraging-Preliminary-Results-from-the-Phase-1b-2a-iLSTA-Trial-Evaluating-Certepetide-in-Locally-Advanced-Non-Resectable-Pancreatic-Duct.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2298322129.HKD","LU1861215975.USD","LU1854103824.USD","LU1978683503.SGD","LU1861220033.SGD","LU2357305700.SGD","LU1861214812.USD","LU0724618433.USD","LU1854104046.USD","ON","IE00B7SZL793.SGD","BK4585","IE00BD6J9T35.USD","LU1861219969.SGD","AEIS","IE0031619046.USD","LU1720051017.SGD","BK4141","BK4139","BK4512","IE00B19Z4B17.USD","IE00B66KJ199.SGD","LU1548497426.USD","LU0348723411.USD","LENZ","LU2360107325.USD","LU0124384867.USD","PST","LU1720051108.HKD","BK4157","IE00BZ199S13.USD","BK4588"],"gpt_icon":0},{"id":"2505414744","title":"Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2505414744","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505414744?lang=en_us&edition=fundamental","pubTime":"2025-01-22 21:00","pubTimestamp":1737550800,"startTime":"0","endTime":"0","summary":"Cohort A data to be presented in a poster session at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. Data reported positive trend in overall survival, including 4 complete responses observed in the certepetide treatment group compared to none in placebo group. Data from Cohort B expected in the coming months, with full data from both cohorts to be reported thereafter. Cohort A of the ASCEND trial completed enrollment in the third quarter of 2023. The preliminary data from Cohort A demonstrate a median overall survival  of 12.68 months for the certepetide treated group, compared to 9.72 months for the placebo treated group. Despite a numerical trend in 6-month PFS favoring the certepet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lisata-therapeutics-reports-encouraging-preliminary-130000586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LSTA","BK4124","SMP","LENZ","BK4139","ORR","PST"],"gpt_icon":0},{"id":"2501393260","title":"Press Release: Logitech Announces Date for Release of Third Quarter Results for Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501393260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501393260?lang=en_us&edition=fundamental","pubTime":"2025-01-07 05:25","pubTimestamp":1736198700,"startTime":"0","endTime":"0","summary":"LAUSANNE, Switzerland & SAN JOSE, Calif.----January 06, 2025--. Logitech International   today announced that it expects to release third quarter fiscal year 2025 financial results on Tuesday, January 28, 2025 at 1:00 p.m. Pacific Standard Time  and 10:00 p.m. Central European Time .There will be a videoconference to discuss these results at 1:30 p.m. PST and 10:30 p.m. CET on the same day.Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A. and/or its affiliates in the U.S. and other countries. All other trademarks are the property of their respective owners. For more information about Logitech and its products, visit the company's website at www.logitech.com.Nicole Kenyon, Head of Global Corporate and Internal Communications - nkenyon@logitech.com ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LOGI","BK4524","PST","LOGN","BK4170","BK4585","BK4588","CET","BK4534","USA"],"gpt_icon":0},{"id":"2501797804","title":"Faraday Future to Host Exclusive Private Showcase and Experience of FX Prototype Mules in Las Vegas, NV","url":"https://stock-news.laohu8.com/highlight/detail?id=2501797804","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501797804?lang=en_us&edition=fundamental","pubTime":"2025-01-06 12:16","pubTimestamp":1736136960,"startTime":"0","endTime":"0","summary":"Faraday Future to Host Exclusive Private Showcase and Experience of FX Prototype Mules, January 5-7 in Las Vegas, NV. . FX prototype mules’ debut and FX strategy updates highlight progress and insights into next steps for FX in Las Vegas, NV from January 5-7.LAS VEGAS, January 06, 2025----Faraday Future Intelligent Electric Inc.  , a California-based global shared intelligent electric mobility ecosystem company, hosts an exclusive private showcase of its Faraday X  prototype mules in Las Vegas, NV from January 5-7, 2025.Exclusive Private Showcase: FX Prototype Mules & Strategy Discussion. FF will unveil the FX prototype mules in a highly interactive, private setting. Attendees will experience firsthand the cutting-edge design, advanced features, and technological capabilities.Broadcast Platforms: FF.com, FF App, and social media channels of FF, Faraday X and YT Jia.Investors : ir@faradayfuture.com Investors : cn-ir@faradayfuture.com Media: john.schilling@ff.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/faraday-future-host-exclusive-private-041600096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4099","BK4555","BK4218","PST","HST","BK4585","BK4588","FFIE","FFIEW","BK4547"],"gpt_icon":1},{"id":"2494089896","title":"Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2494089896","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494089896?lang=en_us&edition=fundamental","pubTime":"2024-12-27 01:21","pubTimestamp":1735233660,"startTime":"0","endTime":"0","summary":"The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative te","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/26/3002002/0/en/Tevogen-Bio-to-Host-Panel-Discussions-AI-In-Biopharma-Next-Frontier-of-Medical-Innovation-and-Pioneering-the-Economics-of-Health-Balancing-Access-and-Outcomes-During-J-P-Morgan-Hea.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2764263203.CNY","IE00BKDWB100.SGD","LU0787776722.HKD","LU2237443895.HKD","FTR","LU1815336760.USD","IE0003U64NQ7.SGD","IE00B3SWFQ91.USD","LU2265009873.SGD","LU1064131342.USD","SG9999014575.USD","LU1244550221.USD","IE00BHPRN162.USD","LU1221951046.USD","LU1301847155.USD","IE00B5TLWC47.USD","LU1116320737.USD","LU0894485498.HKD","IE00BYQQ9H92.USD","SGXZ99366536.SGD","LU0323240290.USD","LU0545039389.USD","LU1035775433.USD","BK4567","LU0345768740.USD","LU0784385170.HKD","IE0005OL40V9.USD","LU1551013342.USD","MSFT","PST","LU2089283258.USD","IE0034235303.USD","LU1861127337.USD","HCSG","LU1868837300.USD","LU0949170426.SGD","IE000KEQY171.SGD","LU0158827781.USD","LU0056508442.USD","LU0868494617.USD","IE00BWXC8680.SGD","LU2242650005.HKD","HST","LU1934455277.USD","IE00BN8TJ469.HKD","LU1366333091.USD","LU1934455194.USD","LU1119994496.HKD","BK4588","IE00B5949003.HKD"],"gpt_icon":1},{"id":"2493076577","title":"Tevogen Bio to Host Panel \"AI In Biopharma: Next Frontier of Medical Innovation\" During the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2493076577","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493076577?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:38","pubTimestamp":1734964680,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Dec.  23, 2024  (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, gene","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/23/3001305/0/en/Tevogen-Bio-to-Host-Panel-AI-In-Biopharma-Next-Frontier-of-Medical-Innovation-During-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2720916845.USD","LU0158827781.USD","IE00BSNM7G36.USD","LU1121112475.USD","LU2360108059.USD","LU1119994496.HKD","LU1815336760.USD","LU0889566641.SGD","LU1720051108.HKD","LU0640476718.USD","LU2106854487.HKD","FTR","LU0345769128.USD","LU1989764664.SGD","PST","LU1868836591.USD","IE00BJJMRX11.SGD","LU2430703095.HKD","MSFT","SG9999014575.USD","BK4548","LU1280957306.USD","LU0251132253.USD","IE0005OL40V9.USD","LU1868836914.USD","LU2237443895.HKD","LU0708994859.HKD","LU1668664300.SGD","IE00B5TLWC47.USD","IE00BJTD4N35.SGD","LU2237443465.HKD","HST","LU1153585028.USD","LU2413666426.HKD","GB00B4LPDJ14.GBP","LU1670710588.SGD","IE00BZ1G4Q59.USD","LU1670711123.USD","LU1506573853.SGD","LU2491049909.HKD","LU1066051498.USD","LU2552382058.USD","LU2023251221.USD","LU2458330243.SGD","LU2404859667.USD","LU1244550494.USD","IE00BQXX3C00.GBP","HCSG","LU0348723411.USD","LU2111349929.HKD"],"gpt_icon":1},{"id":"2492996002","title":"Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492996002","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492996002?lang=en_us&edition=fundamental","pubTime":"2024-12-18 02:32","pubTimestamp":1734460320,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Dec.  17, 2024  (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/17/2998537/0/en/Tevogen-Bio-to-Host-Panel-Pioneering-the-Economics-of-Health-Balancing-Access-and-Outcomes-During-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU1668664300.SGD","LU1363072403.SGD","LU0106261372.USD","LU2023251221.USD","BK4504","LU0158827948.USD","LU1720051017.SGD","LU0320765646.SGD","BK4516","LU0971096721.USD","LU0158827781.USD","BK4588","BK4127","LU0267386448.USD","HCSG","IE00BKVL7J92.USD","LU2357305700.SGD","IE00BZ1G4Q59.USD","BK4585","BK4137","LU2111349929.HKD","LU2271345857.HKD","BK4181","LU2089284900.SGD","HST","LU1074936037.SGD","LU1548497426.USD","LU0006306889.USD","LU0098860793.USD","LU1162221912.USD","PST","LU1720051108.HKD","LU1989772923.USD","LU2028103732.USD","BK4218","LU2089283258.USD","LU0106831901.USD","BK4534","LU0225283273.USD","LU1989772840.SGD","BK4581"],"gpt_icon":0},{"id":"2492601096","title":"New to the Street Show #617 Airs Tonight on Fox Business at 10:30 PM PST as Sponsored Programming","url":"https://stock-news.laohu8.com/highlight/detail?id=2492601096","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492601096?lang=en_us&edition=fundamental","pubTime":"2024-12-17 11:55","pubTimestamp":1734407700,"startTime":"0","endTime":"0","summary":"Featuring Banzai, Modular Medical, Innovative Eyewear Inc., Sustainable Green Team, and Sekur Private Data's ‘Hack of the Week'. NEW YORK CITY, NY / ACCESSWIRE / December 16, 2024 / New to The Street, one of the longest-running sponsored programming television brands, announces its Show #617, airing tonight on Fox Business at 10:30 PM PST. This episode features in-depth interviews with Banzai, Modular Medical , Innovative Eyewear Inc. , and Sustainable Green Team , along with a special segment from Sekur Private Data Ltd.  and its popular ‘Hack of the Week' feature.Tune in to Show #617 Tonight, December 16, 2024, on Fox Business at 10:30 PM PST.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/b7uodDKLEm7UhcQI6TVgTw--~B/aD00NDA7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/8f7d0e6a27da210136d266aafa8d53f1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/b7uodDKLEm7UhcQI6TVgTw--~B/aD00NDA7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/8f7d0e6a27da210136d266aafa8d53f1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/street-show-617-airs-tonight-035500854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","NQmain","BK4198",".IXIC","LUCYW","PSQ","MODD","LUCY","NVIW.SI","MNQmain","QID","SQQQ","TQQQ","TSYW.SI","USJW.SI","BK4082","USAW.SI","PST"],"gpt_icon":1},{"id":"2489495831","title":"L.B. Foster Company to Present at Singular Research’s Best of the Uncovereds Conference on December 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2489495831","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489495831?lang=en_us&edition=fundamental","pubTime":"2024-12-06 02:00","pubTimestamp":1733421600,"startTime":"0","endTime":"0","summary":"PITTSBURGH, Dec.  05, 2024  (GLOBE NEWSWIRE) -- L.B. Foster Company (NASDAQ: FSTR, the “Company”), announced today that John Kasel, President and Chief Executive Officer, and Bill Thalman, Executive V","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/05/2992619/32958/en/L-B-Foster-Company-to-Present-at-Singular-Research-s-Best-of-the-Uncovereds-Conference-on-December-12-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","FSTR","PST"],"gpt_icon":0},{"id":"2488914703","title":"Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2488914703","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488914703?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:49","pubTimestamp":1733230140,"startTime":"0","endTime":"0","summary":"Data showcased at SABCS and ASH reflect progress and growth of Jazz's research and development in oncology and demonstrate ongoing efforts to redefine what is possible for cancer treatment. DUBLIN, Dec. 3, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc  today announced that the Company and its partners will present two abstracts at the 2024 San Antonio Breast Cancer Symposium  fromDecember 10-13 and 13 abstracts at the 66th AnnualAmerican Society of Hematology Annual Meeting fromDecember 7-10.A trial-in-progress poster presentation at SABCS outlines the trial design of the ongoing Phase 3 EmpowHER-303 trial , which is evaluating the efficacy and safety of Ziihera  vs trastuzumab with chemotherapy in patients with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, trastuzumab deruxtecan. New data from a Phase 1b/2 studyof zanidatamab plus evorpacept in patients with pre-treated HER2-positive and HER2-low metastatic breast cancer will be featured as a pos","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/z9XurA.79rXKO7Hh4sqh5w--~B/aD02Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/095ab4a08f01b2302a3f1586ae50e031","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/z9XurA.79rXKO7Hh4sqh5w--~B/aD02Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/095ab4a08f01b2302a3f1586ae50e031"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-present-advancements-solid-124900646.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-present-advancements-solid-124900646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NGS","BTC","LU0320765992.SGD","PST","BK4132","LU0889565916.HKD","LU0471298777.SGD","BK4123","AFG","BK4588","BK4179","BK4007","BK4532","GO","LU0385154629.USD","BK4107","BK4117","BK4585","BK4533","JAZZ","CDC","BK4547","BK4113","ASH","HSCT","BK4109","HMA","VOD","LU0109394709.USD","LU2463526074.USD"],"gpt_icon":1},{"id":"2488957110","title":"Daiichi Sankyo Highlights Progress Across Oncology Portfolio in Multiple Solid and Blood Cancers at ESMO Asia, SABCS and ASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2488957110","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488957110?lang=en_us&edition=fundamental","pubTime":"2024-12-02 21:00","pubTimestamp":1733144400,"startTime":"0","endTime":"0","summary":"Three late-breaking presentations across lung and breast cancer trials of three DXd ADCs to be showcased. Science & Technology Day to provide overview of data and strategy across Daiichi Sankyo R&D pipeline. BASKING RIDGE, N.J., December 02, 2024----Daiichi Sankyo  will present new clinical research across its oncology portfolio with more than 45 abstracts in multiple types of solid and blood cancers at the 2024 ESMO Asia Congress , San Antonio Breast Cancer Symposium  and American Society of Hematology  Annual Meeting prior to its Science & Technology Day.\"Important updates in difficult-to-treat cancers including lung, breast, gastric and biliary tract cancer as well as acute myeloid leukemia and peripheral T-cell lymphoma will be highlighted at these upcoming meetings,\" said Ken Takeshita, MD, Global Head, R&D, Daiichi Sankyo. \"We continue to make important progress with our approved and pipeline medicines with the goal of changing the standard of care across a wide range of cancers.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cY88dbmI1XxsMFQZFBouAA--~B/aD00NzQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/833a7ce6e6a3c8b494d8cbffdb4e6c79","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cY88dbmI1XxsMFQZFBouAA--~B/aD00NzQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/833a7ce6e6a3c8b494d8cbffdb4e6c79"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/daiichi-sankyo-highlights-progress-across-130000400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBD","ASH","PST","BK4007","LU2463526074.USD","BK4109","BK4097","LU2065732104.USD","BK4162","DSKYF","IHC","PRGS","DSNKY","CST"],"gpt_icon":0},{"id":"2483538270","title":"New to the Street to Showcase Innovators in Electric Vehicles, Water Solutions, Environmental Conservation, and Cybersecurity on Fox Business: Episode 612 Airs Monday, November 18 at 10:30 PM PST","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538270","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483538270?lang=en_us&edition=fundamental","pubTime":"2024-11-16 05:05","pubTimestamp":1731704700,"startTime":"0","endTime":"0","summary":"NEW YORK, NY / ACCESSWIRE / November 15, 2024 / New to The Street, the premier platform for spotlighting industry pioneers, announces Episode 612 featuring exclusive interviews with leaders in electric vehicles, sustainable water solutions, environmental conservation, and secure communications. Airing as sponsored programming on Fox Business on Monday, November 18 at 10:30 PM PST, this episode provides viewers with insights into some of the most exciting advancements in technology, sustainability, and cybersecurity.CEO Swin Chatsuwan will discuss Zapp's recent regulatory approval in Thailand and the company's plans for expansion across Asia and Europe. Zapp is a leader in high-performance electric two-wheelers, blending powerful performance with eco-friendly urban mobility solutions. Learn more at zappev.com.CEO Riggs Eckelberry will address the pressing need for sustainable water management solutions. OriginClear is a trailblazer in decentralized water treatment, empowering businesses","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/SwBiAbNHHAdoLR70wIjxig--~B/aD01MTI7dz0zODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6823ced98fa67c5e16ad71173c19d657","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/SwBiAbNHHAdoLR70wIjxig--~B/aD01MTI7dz0zODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/6823ced98fa67c5e16ad71173c19d657"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/street-showcase-innovators-electric-vehicles-210500605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZAPPW","PST","BK4161","BK4091","ZAPP","OCLN"],"gpt_icon":0},{"id":"2483755002","title":"Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS","url":"https://stock-news.laohu8.com/highlight/detail?id=2483755002","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483755002?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502800,"startTime":"0","endTime":"0","summary":"BASKING RIDGE, N.J., November 13, 2024----Daiichi Sankyo  will highlight new clinical research and real-world data from seven abstracts for TURALIO  at the Connective Tissue Oncology Society  2024 Annual Meeting.TURALIO is the first and only oral systemic therapy approved in the U.S. for adult patients with tenosynovial giant cell tumor  associated with severe morbidity or functional limitations and not amenable to improvement with surgery. TGCT is a rare and typically non-malignant tumor that affects small and large joints.1,2,3. \"These latest data being presented at CTOS continue to support the role of TURALIO as a treatment option for certain patients with tenosynovial giant cell tumor,\" said Dan Switzer, Head of U.S. Oncology Business, Daiichi Sankyo, Inc. \"As a leader in TGCT research and development, Daiichi Sankyo has made significant progress in transforming the treatment landscape for patients with this rare, debilitating tumor and we remain committed to educating the medical ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Q_Ud.j.faz9TGQm1x1aHQg--~B/aD0yODA7dz0yNjc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0eaf3e57716fb77929dd27bf6662f931","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Q_Ud.j.faz9TGQm1x1aHQg--~B/aD0yODA7dz0yNjc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0eaf3e57716fb77929dd27bf6662f931"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/daiichi-sankyo-showcase-turalio-research-130000028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AST","ALT","BK4139","LU1878469433.USD","DSKYF","PST","CTOS","DSNKY","BK4104","BK4007","GGT"],"gpt_icon":0},{"id":"2481905134","title":"AstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481905134","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481905134?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980800,"startTime":"0","endTime":"0","summary":"First results from AMPLIFY trial will reinforce CALQUENCE as leading second-generation BTK inhibitor in frontline chronic lymphocytic leukemia with fixed-duration regimen. Next generation cell therapy and T-cell engagers will demonstrate promising early results in multiple types of blood cancer. WILMINGTON, Del., November 07, 2024----AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading and diverse pipeline in hematology at the 66th American Society of Hematology  Annual Meeting and Exposition December 7-10, 2024.Christophe Hotermans, Senior Vice President, Head of Global Medical Affairs, Alexion, said: \"Our ASH presentations will highlight the transformative impact of our medicines, including new analyses from the ALPHA Phase III trial reaffirming the safety and efficacy of our first-in-class Factor D inhibitor, VOYDEYA as add-on to ULTOMIRIS or SOLIRIS for the subset of patients with PNH experiencing clinically significant extravascular h","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sxTLZDXjyixVo0t2ymPKmA--~B/aD00NzU7dz0xNDM4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/5be4b70c947690ffb1d01c948a0a8945","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sxTLZDXjyixVo0t2ymPKmA--~B/aD00NzU7dz0xNDM4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/5be4b70c947690ffb1d01c948a0a8945"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-showcases-strength-hematology-portfolio-120000651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4006","LU2286300806.USD","LU2462157665.USD","IE00B19Z6F94.USD","LU2417539215.USD","BK4561","BK4568","ED","EVH","LU1829250122.USD","IE0031619046.USD","PST","BK4208","AL","IE00B19Z4B17.USD","LU0053671581.USD","LU0170899867.USD","LU0889565916.HKD","BK4167","BK4585","IE0034390439.USD","ASH","BK4539","AZN","LU2236285917.USD","BK4007","LU0320765992.SGD","BK4560","BK4109","BK4097","S","BK4588","IE00B7SZL793.SGD","PML","LU0109394709.USD","LU2346227817.USD","BK4572","LU2463526074.USD","BK4104","CRS","LU2456880835.USD","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2481606707","title":"Aemetis to Review Third Quarter 2024 Financial Results on November 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481606707","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481606707?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:00","pubTimestamp":1730898000,"startTime":"0","endTime":"0","summary":"CUPERTINO, Calif., Nov.  06, 2024  (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its third quarter 2024 earnings repo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/06/2975658/0/en/Aemetis-to-Review-Third-Quarter-2024-Financial-Results-on-November-12-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PST","BK4138","AMTX"],"gpt_icon":1},{"id":"2481656498","title":"Elevance Health Announces Appearance at UBS Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2481656498","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481656498?lang=en_us&edition=fundamental","pubTime":"2024-11-06 05:05","pubTimestamp":1730840700,"startTime":"0","endTime":"0","summary":"For those unable to listen to the live webcast, a replay will be available for 90 days following the presentation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elevance-health-announces-appearance-ubs-210500802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1489326972.SGD","LU0061474960.USD","LU0314106906.USD","LU2357305700.SGD","BK4154","LU2244417387.USD","LU1670628061.USD","LU2362541273.HKD","LU1023059063.AUD","LU1057294990.SGD","HCSG","LU1280957306.USD","LU0266013472.USD","LU0070302665.USD","LU1548497426.USD","LU0345770993.USD","LU2237957902.USD","BK4585","LU0251131958.USD","BK4588","LU0211331839.USD","LU1720051017.SGD","LU0957791311.USD","LU1815333072.USD","LU2592432038.USD","LU2430703178.SGD","LU2362540622.SGD","SG9999003800.SGD","LU0170899867.USD","LU0433182093.SGD","LU0320765489.SGD","LU2430703251.USD","LU0345770308.USD","LU0068578508.USD","LU2430703095.HKD","LU0058720904.USD","LU0114720955.EUR","LU0289739699.SGD","LU0251142724.SGD","LU0985489474.SGD","LU1506573853.SGD","LU1720051108.HKD","LU2505996509.AUD","LU0882574055.USD","ELV","PST","LU0006306889.USD","LU2237957811.SGD","BK4137","LU0640476718.USD"],"gpt_icon":0},{"id":"2479082250","title":"LogicMark, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479082250","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479082250?lang=en_us&edition=fundamental","pubTime":"2024-10-31 21:15","pubTimestamp":1730380500,"startTime":"0","endTime":"0","summary":"LOUISVILLE, Ky., Oct.  31, 2024  (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/31/2972725/0/en/LogicMark-Inc-to-Announce-Third-Quarter-2024-Financial-Results-on-November-12-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4082","PST","LGMK"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PST\",params:#limit:5,,,undefined,":[{"date":"2025-03-26","symbol":"PST","amount":0.166351,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"ProShares UltraShort Lehman 7-10 Year Treasury","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"},{"date":"2024-12-23","symbol":"PST","amount":0.244156,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"ProShares UltraShort Lehman 7-10 Year Treasury","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-31"},{"date":"2024-09-25","symbol":"PST","amount":0.221,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-25","defaultRemindTime":1727271000000,"name":"ProShares UltraShort Lehman 7-10 Year Treasury","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-25","currency":"USD","dateTimestamp":1727236800000,"payDate":"2024-10-02"},{"date":"2024-06-26","symbol":"PST","amount":0.23527,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-26","defaultRemindTime":1719408600000,"name":"ProShares UltraShort Lehman 7-10 Year Treasury","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-03","payableDate":"2024-06-26","currency":"USD","dateTimestamp":1719374400000,"payDate":"2024-07-03"},{"date":"2024-03-20","symbol":"PST","amount":0.163911,"announcedDate":"2024-03-19","type":"dividend","market":"US","newRecordDate":"2024-03-21","defaultRemindTime":1710941400000,"name":"ProShares UltraShort Lehman 7-10 Year Treasury","recordDate":"2024-03-27","payableDate":"2024-03-21","currency":"USD","dateTimestamp":1710907200000,"payDate":"2024-03-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PST\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-20","recordDate":"2018-06-21","paymentDate":"2018-06-27","value":0.0088,"currency":"USD"},{"executeDate":"2018-09-26","recordDate":"2018-09-27","paymentDate":"2018-10-03","value":0.055529,"currency":"USD"},{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2019-01-03","value":0.080408,"currency":"USD"},{"executeDate":"2019-03-20","recordDate":"2019-03-21","paymentDate":"2019-03-27","value":0.064496,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.101851,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PST\",market:\"US\",delay:false,,,undefined,":{}}}